JE

Julie Eastland

Chief Executive Officer, President and Director

Zentalis Pharmaceuticals

Therapeutic Areas

Zentalis Pharmaceuticals Pipeline

DrugIndicationPhase
Azenosertib (ZN-c3)Cyclin E1+ Platinum-Resistant Ovarian Cancer (PROC)Phase 2